1 / 27

When Using DOPPS Slides

This study analyzes the economic incentives and healthcare outcomes associated with end-stage renal disease (ESRD) through the DOPPS framework. It examines various factors, including incidence and prevalence rates, mortality statistics, and annual expenditures per ESRD patient across different countries. We evaluate the impact of nephrologist income, patient-physician contact time, and adherence to KDOQI guidelines on treatment outcomes. Our findings reveal correlations between healthcare expenditure and both process and outcome variables, providing insights for health policy improvements in ESRD management.

nellie
Download Presentation

When Using DOPPS Slides

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. When Using DOPPS Slides

  2. DOPPS Slide Use Guidelines

  3. End-stage renal disease and economic incentives: The International Study of Health Care Organization and Financing

  4. Introduction

  5. DOPPS Background

  6. ISHCOF Methods: Data Sources

  7. ISHCOF Methods: Expenditure Data

  8. Input Price Parity Index Construction

  9. Input Price Parity Index: Example Calculations

  10. Incidence and Prevalence Rates for ESRD, 2002

  11. Death Rates for the General and the DOPPS II HD Populations Both sexes, aged 55-69, by country

  12. Death Rates for the General and the DOPPS II HD Populations Males, aged 55-69, by country

  13. Death Rates for the General and the DOPPS II HD Populations Females, aged 55-69, by country

  14. Annual Expenditure per ESRD Patient and General Population Health Expenditure per Capita, 2003

  15. Use of the IPP Index to Estimate Annual Expenditure per ESRD Patient in 2002

  16. ESRD Expenditures (PPP and IPP) and Mortality, 2002

  17. Payment Systems for Health Care

  18. Intermediate Outcomes for Nutrition and Anemia: % HD Patients Achieving KDOQI Guidelines

  19. Definitions of Process Variables

  20. Process Variables and Inputs

  21. HD Patient-Physician Contact Time and Nephrologist Income, 2002

  22. Cost and Payment for HD Treatments in 2002 a

  23. ESRD Incidence and Gross National Income per Capita, 2002

  24. Correlations between Annual Expenditure per ESRD Patient and both Process and Outcome Variables

  25. Conclusions (1)

  26. Conclusions (2)

  27. Acknowledgements

More Related